PMID- 11741555 OWN - NLM STAT- MEDLINE DCOM- 20020110 LR - 20190622 IS - 0002-9149 (Print) IS - 0002-9149 (Linking) VI - 88 IP - 12 DP - 2001 Dec 15 TI - Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy. PG - 1374-8 AB - Dobutamine stress echo provides potentially useful information on idiopathic dilated cardiomyopathy (IDC). From February 1, 1997, to October 1, 1999, 186 patients (131 men and 55 women, mean age 56 +/- 12 years) with IDC, ejection fraction <35%, and angiographically normal coronary arteries were studied by high-dose (up to 40 micro/kg/min) dobutamine echo in 6 centers, all quality controlled for stress echo reading. In all patients, wall motion score index (WMSI) (from 1 = normal to 4 = dyskinetic in a 16- segment model of the left ventricle) was evaluated by echo at baseline and peak dobutamine. One hundred eighty-four patients were followed up (mean 15 +/- 13 months) and only cardiac death was considered as an end point. There were 29 cardiac deaths. Significant parameters for survival prediction at univariate analysis are: DeltaWMSI (chi-square 20.1; p <0.0000), New York Heart Association (NYHA) class (chi-square 17.57; p <0.0000), rest ejection fraction (chi-square 10.41; p = 0.0013), angiotensin-converting enzyme inhibitors (chi-square 8.23; p = 0.0041), and hypertension (chi-square 8.08, p = 0.0045). In the multivariate stepwise analysis only DeltaWMSI and NYHA were independent predictors of outcome (DeltaWMSI = hazard ratio 0.02, p < 0.0000; NYHA class = hazard ratio 3.83, p < 0.0000). Kaplan-Meier survival estimates showed a better outcome for patients with a large inotropic response (DeltaWMSI > or =0.44, a cutoff identified by receiver-operating characteristic curves analysis) than for those with a small or no myocardial inotropic response to dobutamine (93.6% vs 69.4%, p = 0.00033). Thus, in patients with IDC, an extensive contractile reserve identified by high-dose dobutamine stress echocardiography is associated with a better survival. FAU - Pratali, L AU - Pratali L AD - C.N.R. Institute of Clinical Physiology, Pisa, Italy. FAU - Picano, E AU - Picano E FAU - Otasevic, P AU - Otasevic P FAU - Vigna, C AU - Vigna C FAU - Palinkas, A AU - Palinkas A FAU - Cortigiani, L AU - Cortigiani L FAU - Dodi, C AU - Dodi C FAU - Bojic, D AU - Bojic D FAU - Varga, A AU - Varga A FAU - Csanady, M AU - Csanady M FAU - Landi, P AU - Landi P LA - eng PT - Clinical Trial PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 SB - IM MH - Aged MH - Cardiomyopathy, Dilated/*diagnostic imaging/mortality MH - *Echocardiography, Stress MH - Female MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - Prospective Studies MH - ROC Curve MH - Survival Rate EDAT- 2001/12/14 10:00 MHDA- 2002/01/11 10:01 CRDT- 2001/12/14 10:00 PHST- 2001/12/14 10:00 [pubmed] PHST- 2002/01/11 10:01 [medline] PHST- 2001/12/14 10:00 [entrez] AID - S0002914901021166 [pii] AID - 10.1016/s0002-9149(01)02116-6 [doi] PST - ppublish SO - Am J Cardiol. 2001 Dec 15;88(12):1374-8. doi: 10.1016/s0002-9149(01)02116-6.